Trending...
- ReadyCommunities Partnership of CCROA Announces National Service Awardees Who Helped Save Passengers from the Derailed Train Near Rural Mendon
- How Do You Build Generational Wealth?
- NEMTAC® Brings Innovation to Accreditation Industry with the Launch of Collaborative Network Built on Distributed Ledger Technology
DURHAM, N.C.--(BUSINESS WIRE)--Precision BioSciences, Inc. (Nasdaq: DTIL) a clinical stage gene editing company developing ARCUS®-based ex vivo allogeneic CAR T and in vivo gene editing therapies, today announced that the Company will participate in the H.C. Wainwright Cell Therapy Virtual Conference taking place February 28, 2023.
Details for the virtual fireside chat are as follows:
Date: Tuesday, February 28, 2023
Time: 2:00 PM ET
The fireside chat will be available via a live webcast accessible on Precision's website in the Investors section under Events & Presentations on February 28, 2023: https://investor.precisionbiosciences.com/events-and-presentations. An archived replay will be available for approximately 30 days following the event.
More on ncarol.com
About Precision BioSciences, Inc.
Precision BioSciences, Inc. is a clinical stage biotechnology company dedicated to improving life (DTIL) with its novel and proprietary ARCUS® genome editing platform. ARCUS is a highly precise and versatile genome editing platform that was designed with therapeutic safety, delivery, and control in mind. Using ARCUS, the Company's pipeline consists of multiple ex vivo "off-the-shelf" CAR T immunotherapy clinical candidates and several in vivo gene editing candidates designed to cure genetic and infectious diseases where no adequate treatments exist. For more information about Precision BioSciences, please visit www.precisionbiosciences.com.
Contacts
Investor Contact:
Mei Burris
Director, Investor Relations & Finance
Mei.burris@precisionbiosciences.com
Media Contact:
Maurissa Messier
Senior Director, Corporate Communications
Maurissa.Messier@precisionbiosciences.com
Details for the virtual fireside chat are as follows:
Date: Tuesday, February 28, 2023
Time: 2:00 PM ET
The fireside chat will be available via a live webcast accessible on Precision's website in the Investors section under Events & Presentations on February 28, 2023: https://investor.precisionbiosciences.com/events-and-presentations. An archived replay will be available for approximately 30 days following the event.
More on ncarol.com
- INshed Now Offers Nationwide Shipping of Fully-Assembled, Eco-Friendly Backyard Offices
- Entrinsik Appoints Madhavi W. Chandra as Chief Product Officer
- Award-winning singer-songwriter Ronnie Call and The Waterz Edge Band has a new tune
- Golden Ticket Productions Launches New Website
- Granite Ridge Townhomes Now Available in Rolesville
About Precision BioSciences, Inc.
Precision BioSciences, Inc. is a clinical stage biotechnology company dedicated to improving life (DTIL) with its novel and proprietary ARCUS® genome editing platform. ARCUS is a highly precise and versatile genome editing platform that was designed with therapeutic safety, delivery, and control in mind. Using ARCUS, the Company's pipeline consists of multiple ex vivo "off-the-shelf" CAR T immunotherapy clinical candidates and several in vivo gene editing candidates designed to cure genetic and infectious diseases where no adequate treatments exist. For more information about Precision BioSciences, please visit www.precisionbiosciences.com.
Contacts
Investor Contact:
Mei Burris
Director, Investor Relations & Finance
Mei.burris@precisionbiosciences.com
Media Contact:
Maurissa Messier
Senior Director, Corporate Communications
Maurissa.Messier@precisionbiosciences.com
Filed Under: Business
0 Comments
Latest on ncarol.com
- Ohio County Commission President & Founder of the Cincinnati Black Music Walk of Fame, Alicia Reece, Announces Grand Opening of New Tourism Attraction
- New York Komedians Presents an Evening of Laughs at Broadway
- Redefining Professional Spaces: The Rise of Dual-Purpose Backyard Office Sheds in America
- How Do You Build Generational Wealth?
- Registration is Now Open for the 2023 CGI Integrated Care Conference
- Precision BioSciences Provides Update on Allogeneic CAR T Programs and Regulatory Path Forward
- Studeo dévoile StudAI : l'Intelligence Artificielle au service de l'éducation
- EMH Productions Announce 'Live for Liberty' Charity Concert in Los Angeles Supporting "Woman, Life, Freedom" Movement in Iran
- NEMTAC® Brings Innovation to Accreditation Industry with the Launch of Collaborative Network Built on Distributed Ledger Technology
- Latino Leaders Network to Honor Mayor Kate Gallego of Phoenix with the Antonio Villaraigosa Leadership Award at the 38th Tribute to Mayors
- New for spring and summer at Lakeview at Fontana resort spa in North Carolina
- Century Fasteners Corp. – Robert D. Botticelli, Hired
- Duke Energy urges customers to plan for 2023 hurricane season
- Levinger-Regens Analytics Reveals New Energy Outlook
- UVify Unveils the Groundbreaking SLAMDAQ
- Dancing Numbers Unveils Google Sheets QuickBooks Integration, Streamlining Data Import, Export, and Deletion
- ReadyCommunities Partnership of CCROA Announces National Service Awardees Who Helped Save Passengers from the Derailed Train Near Rural Mendon
- LOWE'S COMPANIES, INC. ANNOUNCES 5% INCREASE TO QUARTERLY CASH DIVIDEND
- Bitcoin Mining Capacity Reaches 350 Exahashes/second
- Up To 70% Off! Alibonnie Graduation Season Wig Surprise Discount